Timon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.50 M
as on 22-06-2024
- Revenue 12.93%
(FY 2019)
- Profit -383.36%
(FY 2019)
- Ebitda -45.15%
(FY 2019)
- Net Worth -54.17%
(FY 2019)
- Total Assets 74.11%
(FY 2019)
About Timon Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Eugene Christy and Jamespremkumar Jamespremkumar serve as directors at the Company.
- CIN/LLPIN
U24232TN2014PTC095527
- Company No.
095527
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2014
- Date of AGM
28 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Timon Pharmaceuticals Private Limited offer?
Timon Pharmaceuticals Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin D3 Tablets & Capsules, Nutraceuticals, Protein Tablet, Ointment, Pharmaceutical Tablets, Body Cream, Anti Acne Cream, Beauty Soap, Acne Soap.
Who are the key members and board of directors at Timon Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eugene Christy  | Director | 18-Mar-2014 | Current |
| Jamespremkumar Jamespremkumar | Director | 18-Mar-2014 | Current |
Financial Performance of Timon Pharmaceuticals.
Timon Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.93% increase. The company also saw a substantial fall in profitability, with a 383.36% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Timon Pharmaceuticals?
In 2018, Timon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Timon Tender Care Pharmaceuticals Private LimitedActive 5 years 1 monthEugene Christy is a mutual person
- Siloam Pharmaceuticals Private LimitedActive 5 years 1 month
Jamespremkumar Jamespremkumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 23 Apr 2015 | ₹2.50 M | Open |
How Many Employees Work at Timon Pharmaceuticals?
Timon Pharmaceuticals has a workforce of 37 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Timon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Timon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
